Explore the Agenda

7:00 am Check In & Coffee

7:50 am Chair’s Opening Remarks

Regaining Control & Stability in Lab & Site Operations

8:00 am Re-Designing Lab Operations for a Constrained Era to Maintain Performance Under Budget, Headcount, & Time Pressure

Associate Manager, R&pD Operations, Regeneron Pharmaceuticals
  •  Identifying where operational spend no longer delivers value by redesigning workflows, roles, and support models to protect critical lab output while eliminating low-impact effort and redundancy
  • Improving asset, space, and workforce utilization by aligning operational priorities to what directly enables scientific productivity, reducing idle equipment time, duplicated purchases, and unplanned downtime
  • Stabilizing delivery timelines and reducing operational risk by moving from reactive firefighting to disciplined, data-informed decision-making that preserves performance despite ongoing budget and staffing constraints

8:30 am Choose Your Own Adventure – Unlock It One Module At a Time

  • Why large-scale operational transformation usually fails under today’s constraints 
  • How a modular approach switches on capability precisely where it delivers most value 
  • How to identify your highest-leverage starting point and prove value before committing further
  • How individual capabilities compound into an integrated operating model over time 
  • A lower-risk, more defensible way to improve lab performance 

9:00 am Adapting Lab Operations to Do More with Less While Protecting Scientific Output

Senior Director - Quality Control, Gilead Sciences
  •  Rethinking how work gets done across the lab by challenging legacy processes, reallocating responsibilities, and refining support structures, cutting out activities that add limited value while safeguarding the work that truly drives results
  • Driving greater efficiency from existing resources by ensuring equipment, lab space, and teams are focused on high-impact priorities, reducing underutilization, avoiding unnecessary spend, and minimizing disruptions to day-to-day operations
  • Creating more predictable and resilient delivery by embedding structured, insight-led decision-making, moving away from reactive problem-solving to a more controlled, forward-looking approach that sustains performance despite constrained budgets and teams

9:30 am Speed Networking

Join our speed networking session tailored for operation leaders, like yourselves, to connect with industry peers about ongoing challenges and opportunities within the rapidly evolving operations space. Elevate your networking experience during this session designed for impactful connections among operations leaders.

10:00 am Diagnozing Where Operations Fail First to Reduce Risk Across Assets, People, & Processes

Associate Director, Facilities, Solid Biosciences
  •  Pinpointing the earliest points of operational failure across equipment, staffing, and workflows to prevent downstream disruption that drives unplanned downtime, emergency spend and delayed scientific delivery
  • Prioritizing investment toward the highest-risk failure points by distinguishing systemic breakdowns from isolated issues, enabling more effective allocation of constrained capital and operational resources
  • Reducing cost of disruption and compliance exposure by establishing leading indicators that signal instability early, allowing corrective action before issues escalate into audit findings, asset loss, or productivity collapse

10:30 am Presentation Reserved for Agilent

11:00 am Morning Break

Networking & Snacks

Track A

Track A: Running the Site

Track A: Running the Site Exploring ways to keep sites running safely and reliably despite reduced resources, ageing infrastructure, and complex outsourcing models. Sessions cover maintenance maturity, facilities risk and regaining operational ownership.

11:30 am Discover: Separating AI Reality from Hype to Identify Where Automation Actually Reduces Operational Workload & Risk

Executive Director - Real Estate & Facilities, Kardigan
  •  Avoiding wasted investment and implementation failure by distinguishing high-value, automation-ready use cases from AI initiatives that lack the data maturity, integration, or scale required to deliver real operational benefit
  • Reducing operational workload and error rates by applying automation only where it replaces repetitive, high-volume tasks with clear ownership and measurable outcomes, rather than adding complexity or oversight burden
  • Lowering operational and compliance risk by deploying human-in-the-loop automation models that improve consistency and decision support without relinquishing accountability or control in regulated environments

11:50 am Discover: Presentation Reserved for Elemental Machines

12:10 pm Discover: Applying Reliability-Centred Maintenance Principles to Extend Asset Lifespan, Reduce Downtime, & Stabilize Operations

Facilities Manager, Alnylam Pharmaceuticals
  • Lowering total cost of ownership for critical assets by shifting maintenance spend from reactive repairs to risk-based, reliability-centred interventions that prevent premature equipment failure
  • Reducing unplanned downtime and operational disruption by identifying high-failure components early and prioritizing maintenance activities that protect asset availability and throughput
  • Stabilizing site performance and budgeting by using failure data and leading indicators to plan maintenance proactively, improving predictability and avoiding emergency labor, parts, and compliance costs

12:30 pm Develop: Shared Q&A

12:45 pm Action: Roundtable Session

Collaborate to identify practical starting points, potential barriers, and strategies for making necessary change.

Interactive Peer-Led Discussion Facilitated by the Chair

Track B

Track B: Running the Lab

Navigating core lab-level inefficiencies that intensify under lean conditions, asset blind spots, duplicated equipment, and unclear role boundaries between scientists and operations.

11:30 am Discover: Rebuilding Asset Visibility & Inventory Control to Improve Uptime, Forecast Spend, & Support Scientists Effectively

Associate Manager - Asset Management, Regeneron Pharmaceuticals
  • Reducing unplanned downtime and service delays by restoring accurate, real-time asset visibility that enables faster issue identification, prioritization, and response
  • Improving budget accuracy and cost control by aligning inventory data with maintenance, service contracts, and utilization patterns, eliminating blind spots that drive unexpected spend
  • Increasing scientific productivity and confidence by ensuring critical equipment availability is predictable, transparent, and proactively managed rather than dependent on ad-hoc knowledge

11:50 am Discover: Presentation Reserved for Azenta

12:10 pm Discover: Managing Role Creep in Lean Lab Environments to Preserve Scientific Productivity & Prevent Operational Burnout

Associate Director - Facilities & Lab Operations, EpiCypher
  • Protecting scientific output and timeline delivery by clearly defining operational ownership and preventing scientists from absorbing administrative, maintenance, and coordination tasks that dilute research focus
  • Reducing hidden labor costs and burnout risk by redesigning role boundaries and support models that allow lean teams to operate sustainably without relying on informal overtime or goodwill
  • Improving operational efficiency and accountability by aligning responsibilities to skills and value creation, ensuring work is performed by the right function at the right cost

12:30 pm Develop: Shared Q&A

12:45 pm Action: Roundtable Session

Collaborate to identify practical starting points, potential barriers, and strategies for making necessary change.

Interactive Peer-Led Discussion Facilitated by the Chair

1:00 pm Lunch & Networking

1:00 pm Kaon Private Lunch

Join this exclusive session hosted by Lab Design Tool to learn how leading $1B+ pharma organizations are recovering $1M+ annually by transforming lab design into a scalable, repeatable operational advantage.

Exploring leadership, governance, and communication failures that create conflict between maintenance, facilities, production, and R&D, and how to realign them.

2:00 pm Discover: Aligning Leadership Priorities Across Site Functions to Reduce Scheduling Conflicts & Operational Friction

Senior Director - Strategic Operations, Monimoi Therapeutics
  • Reducing wasted labor, idle assets, and re-work by establishing shared priorities across maintenance, facilities, lab ops, and R&D that minimize last-minute schedule changes and conflicting demands
  • Improving asset availability and delivery predictability by synchronizing production, lab usage, and maintenance planning, enabling more effective use of limited windows and resources
  • Increasing decision speed and accountability by providing leaders with a common operational framework that clarifies tradeoffs, escalations, and ownership when priorities compete

2:20 pm Discover: Presentation Reserved for C&W Services

2:40 pm Discover: Standardizing Site-Level Governance Models to Enable Faster Decisions & Clearer Accountability

Global Director, Facilities & Workplace Experience, ACADIA Pharmaceuticals Inc.
  •  Reducing operational delays and costly indecision by standardizing decision rights, escalation paths, and ownership across site functions, eliminating confusion when priorities conflict
  • Improving execution speed and consistency across sites by replacing ad-hoc, person-dependent decision-making with repeatable governance frameworks that scale reliably as organizations grow or contract
  • Lowering operational and compliance risk by ensuring accountability is explicit and auditable, reducing gaps that lead to missed actions, duplicated work, or exposure during inspections and incident response

3:00 pm Develop: Shared Q&A

3:15 pm Action: Roundtable Session

Collaborate to identify practical starting points, potential barriers, and strategies for making necessary change.

Interactive Peer-Led Discussion Facilitated by the Chair

Advancing process design, workload distribution, and operational decision-making that allows labs to function effectively under sustained pressure.

2:00 pm Discover: Designing Lean Lab Workflows to Maintain Throughput & Data Quality With Fewer People

Lab Operations lead, Empress Therapeutics
  • Sustaining experimental throughput and data integrity by redesigning lab workflows to eliminate non-value-adding steps, reduce hand-offs, and minimize rework despite reduced staffing levels
  • Lowering operational cost per experiment by standardizing processes and optimizing task sequencing, enabling smaller teams to deliver consistent output without reliance on overtime or informal workarounds
  • Reducing error rates and compliance risk by embedding quality controls directly into lean workflows, ensuring reliability and reproducibility are maintained even as resources are constrained

2:20 pm Discover: Presentation Reserved for PHCNA

2:40 pm Discover: Reducing Scientific Delays by Clarifying Ownership Between Lab Ops, Facilities, & Vendors

Lab Operations Specialist, Novartis AG
  • Reducing experiment delays and schedule slippage by clearly defining ownership, decision rights, and offs across lab ops, facilities, and external vendors, eliminating wait states and miscommunication
  • Lowering hidden operational costs by preventing duplicated effort, rework, and escalation cycles caused by unclear responsibility for equipment readiness, maintenance, and issue resolution
  • Improving equipment availability and researcher confidence by establishing predictable support models that ensure problems are addressed quickly by the correct function, protecting scientific timelines and data delivery

3:00 pm Develop: Shared Q&A

3:15 pm Action: Roundtable Session

Collaborate to identify practical starting points, potential barriers, and strategies for making necessary change.

Interactive Peer-Led Discussion Facilitated by the Chair

3:30 pm Partner Spotlight: Reserved for Calira

3:40 pm Afternoon Break & Networking

Pressure‑Testing How Operations Are Run to Prevent Costly Breakdown Under Real Conditions

4:10 pm Roundtable: Scaling Biotech Operations Without Compromise: Aligning IT, Facilities & Lab Infrastructure to Enable Clinical & Commercial Success

Director - Laboratory Operations, Vivodyne
  • Integrating IT, Facilities, and Lab Operations to drive scalable performance: Breaking down silos to create a unified infrastructure that supports growth across sites and geographies
  • Balancing capital investment with risk, compliance, and speed: Making smarter decisions on real estate, infrastructure, and systems while maintaining regulatory readiness
  • Engaging leadership and the board to secure buy-in for transformation: Translating operational complexity into clear business cases to unlock funding and accelerate execution

4:40 pm Building & Scaling a Proprietary Chemical Inventory System to Meet Evolving Operational & Regulatory Demands

Executive Director - Laboratory Operations & Facilities, Eli Lilly & Co.
  • Develop and scaled an in-house inventory system to improve visibility and operational efficiency
  • Adapt the platform during the Cambridge to Boston transition to support increased scale and complexity
  • Align the system with Boston-specific regulations to strengthen compliance and risk control

5:10 pm Panel: Making Intentional Insourcing & Outsourcing Decisions to Balance Cost, Control, & Capability

Senior Director - Strategic Operations, Monimoi Therapeutics
  • Optimizing total operating cost without sacrificing reliability by deliberately defining which capabilities must remain in-house and which can be outsourced, avoiding false savings that lead to delays, rework, or quality issues
  • Improving responsiveness and accountability by aligning insourcing and outsourcing decisions to business-critical activities, ensuring ownership, escalation, and performance expectations are clear across internal teams and suppliers
  • Reducing operational and compliance risk by selecting operating models that match organizational maturity and capacity, preventing over-outsourcing of core knowledge or under-resourcing of critical support functions

5:40 pm Chair’s Closing Remarks

5:50 pm End of Conference Day One